Skip to content

Evaluation of Seelens AF, an Aspheric Intra-ocular Lens

Clinical Evaluation of the Aspheric SeeLens AF Intra-ocular Lens.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00825747
Enrollment
0
Registered
2009-01-21
Start date
2009-01-31
Completion date
2010-01-31
Last updated
2021-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Cataract, Cataract surgery, intraocular lens, Aspheric lens

Brief summary

Senile cataract is managed by cataract extraction and intra-ocular lens (IOL) implantation. The purpose of this study is to evaluate the safety and efficacy of the SeeLens AF, an acrylic hydrophilic aspheric IOL. This lens was designed to reduce vision aberrations and secondary cataract formation rate. Preoperative evaluation: Best corrected visual acuity, refraction, comprehensive slit lamp examination and biometry. Surgical procedure: Cataract surgery using a clear corneal incision (1.8mm to2.4mm), phacoemulsification and implantation of the SeeLens AF to the capsular bag. IOL implantation parameters will be evaluated by the surgeon. Postoperative follow up: Best corrected visual acuity, uncorrected visual acuity, refraction and comprehensive slit lamp examinations up to 3 months after surgery.

Interventions

DEVICESeeLens AF intra-ocular lens

the SeeLens AF is an acrylic hydrophilic C shaped haptics intra-ocular lens, designed for implantation in the lenticular capsular bag or the sulcus during cataract surgery.

Sponsors

Hanita Lenses
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Senile Cataract * Age \>18 years * Cataract extraction using phacoemulsification * Corneal incision less than 1.5 mm

Exclusion criteria

* Allergy/sensitivity to eye drops used during and after cataract surgery * Amblyopia/ strabismus * Ocular disease, other than cataract, diminishing visual acuity, such as corneal opacity, advanced glaucoma, diabetic retinopathy, exudative or moderate to severe non-exudative age-related macular degeneration, uveitis. * previous ocular surgery or ocular trauma in the investigated eye * Ocular anomaly, such as microphthalmos * Keratometry values less than 40 diopters or more than 47 diopters. * Ocular axial length less than 21.0 mm or longer than 25.0 mm * Intra-operative complications prior to intraocular lens implantation, such as tear of the posterior capsule. * posterior capsular scar * visual acuity in the fellow eye less than 20/200

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity 3 months after SeeLens AF implantation3 months

Secondary

MeasureTime frame
Complications related to SeeLens AF implantation during cataract surgery.3 months
Postoperative severe intra-ocular inflammation or infection3 months
Prediction of ocular refraction after cataract surgery with Seelens AF implantation3 months

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026